Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CELGENE CORP /DE/ | 246,962 | reported | 20 Nov 2019 | tx 280+1,586,865−1,977,569 |
| BIOMARIN PHARMACEUTICAL INC | 15,095 | reported | 23 May 2023 | tx 4+15,095 |
| Syros Pharmaceuticals, Inc. | 5,334 | reported | 16 Sept 2023 | tx 11+130,166−2,666 |
| Turning Point Therapeutics, Inc. | 0 | reported | 17 Aug 2022 | tx 6+19,209−19,209 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Sept 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,666 | — | |
| 16 Sept 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,666 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | deriv |
| 23 May 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,190 | 0.00 USD | |
| 31 Oct 2022 | PURCHASE | BIOMARIN PHARMACEUTICAL INC | 3,625 | 86.75 USD | first after silence |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 8,000 | 0.00 USD | deriv |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 2,000 | 76.00 USD | |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 209 | — | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 17,000 | — | deriv |
| 01 Jun 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 24 May 2022 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,980 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 2,300 | 0.00 USD | |
| 21 Jun 2021 | PURCHASE | Turning Point Therapeutics, Inc. | 2,000 | 81.34 USD | first after silence |
| 08 Jun 2021 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 209 | 0.00 USD | deriv |
| 24 May 2021 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 17,000 | 0.00 USD | deriv |
| 11 Jun 2020 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 13 May 2020 | PURCHASE | Syros Pharmaceuticals, Inc. | 10,000 | 8.86 USD | first after silence |
| 19 Dec 2019 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 20 Nov 2019 | OTHER | CELGENE CORP /DE/ | 29,669 | 0.00 USD | deriv |
| 20 Nov 2019 | OTHER | CELGENE CORP /DE/ | 29,669 | 0.00 USD | deriv |
| 20 Nov 2019 | OTHER | CELGENE CORP /DE/ | 33,880 | 0.00 USD | deriv |
| 20 Nov 2019 | OTHER | CELGENE CORP /DE/ | 33,881 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 31 Oct 2022.